Literature DB >> 27694109

Messages to Motivate Human Papillomavirus Vaccination: National Studies of Parents and Physicians.

Teri L Malo1, Melissa B Gilkey2, Megan E Hall3, Parth D Shah3, Noel T Brewer1.   

Abstract

BACKGROUND: Physician communication about human papillomavirus (HPV) vaccine is a key determinant of uptake. To support physician communication, we sought to identify messages that would motivate HPV vaccination.
METHODS: From 2014 to 2015, we surveyed national samples of parents of adolescents ages 11 to 17 (n = 1,504) and primary care physicians (n = 776). Parents read motivational messages, selected from nine longer messages developed by the Centers for Disease Control and Prevention and six brief messages developed by the study team. Parents indicated whether each message would persuade them to get HPV vaccine for their adolescents. Physicians read the brief messages and indicated whether they would use them to persuade parents to get HPV vaccine for 11- to 12-year-old children.
RESULTS: The highest proportion of parents (65%) and physicians (69%) found this brief message to be persuasive: "I strongly believe in the importance of this cancer-preventing vaccine for [child's name]." Parents disinclined to vaccinate were most receptive to messages with information about HPV infection being common, cancers caused by HPV, and HPV vaccine effectiveness. Parents' endorsement did not vary by race/ethnicity, education, child age, or child sex (all P > 0.05).
CONCLUSIONS: Our national surveys of parents and physicians identified messages that could motivate HPV vaccination, even among parents disinclined to vaccinate their children. The lack of difference across demographic subgroups in parental endorsement may suggest that these messages can be used across these subgroups. IMPACT: Our findings support physicians' use of these messages with parents to help motivate uptake of this important cancer-preventing vaccine. Cancer Epidemiol Biomarkers Prev; 25(10); 1383-91. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694109      PMCID: PMC5108584          DOI: 10.1158/1055-9965.EPI-16-0224

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

Authors:  Susan T Vadaparampil; Teri L Malo; Jessica A Kahn; Daniel A Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard G Roetzheim; Karen L Bruder; Tina M Proveaux; Xiuhua Zhao; Neal A Halsey; Anna R Giuliano
Journal:  Am J Prev Med       Date:  2014-01       Impact factor: 5.043

2.  Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.

Authors:  Kelly R Ylitalo; Hedwig Lee; Neil K Mehta
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

3.  Quality of physician communication about human papillomavirus vaccine: findings from a national survey.

Authors:  Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

4.  HPV vaccination among adolescent males: results from the National Immunization Survey-Teen.

Authors:  Paul L Reiter; Melissa B Gilkey; Noel T Brewer
Journal:  Vaccine       Date:  2013-04-16       Impact factor: 3.641

5.  Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?

Authors:  Melissa B Gilkey; Jennifer L Moss; Tamera Coyne-Beasley; Megan E Hall; Parth D Shah; Noel T Brewer
Journal:  Prev Med       Date:  2015-06-04       Impact factor: 4.018

6.  HPV vaccine hesitancy: findings from a statewide survey of health care providers.

Authors:  Annie-Laurie McRee; Melissa B Gilkey; Amanda F Dempsey
Journal:  J Pediatr Health Care       Date:  2014-07-10       Impact factor: 1.812

7.  Provider communication and HPV vaccination: The impact of recommendation quality.

Authors:  Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer
Journal:  Vaccine       Date:  2016-01-24       Impact factor: 3.641

Review 8.  Appealing to fear: A meta-analysis of fear appeal effectiveness and theories.

Authors:  Melanie B Tannenbaum; Justin Hepler; Rick S Zimmerman; Lindsey Saul; Samantha Jacobs; Kristina Wilson; Dolores Albarracín
Journal:  Psychol Bull       Date:  2015-11       Impact factor: 17.737

9.  Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-26       Impact factor: 17.586

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

View more
  13 in total

1.  Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey.

Authors:  Emily B Walling; Sherry Dodd; Neil Bobenhouse; Evelyn Cohen Reis; Randy Sterkel; Jane Garbutt
Journal:  Am J Prev Med       Date:  2019-01       Impact factor: 5.043

2.  Questions and Concerns About HPV Vaccine: A Communication Experiment.

Authors:  Parth D Shah; William A Calo; Melissa B Gilkey; Marcella H Boynton; Susan Alton Dailey; Karen G Todd; Meagan O Robichaud; Marjorie A Margolis; Noel T Brewer
Journal:  Pediatrics       Date:  2019-01-22       Impact factor: 7.124

3.  Effect of a multi-component intervention on providers' HPV vaccine communication.

Authors:  Rebecca B Perkins; Bolanle Banigbe; Anny T Fenton; Amanda K O'Grady; Emily M Jansen; Judith L Bernstein; Natalie P Joseph; Terresa J Eun; Dea L Biancarelli; Mari-Lynn Drainoni
Journal:  Hum Vaccin Immunother       Date:  2020-05-13       Impact factor: 3.452

4.  Support for Pharmacist-Provided HPV Vaccination: National Surveys of U.S. Physicians and Parents.

Authors:  Parth D Shah; William A Calo; Macary W Marciniak; Melissa B Gilkey; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-05       Impact factor: 4.254

5.  Parents' Views on the Best and Worst Reasons for Guideline-Consistent HPV Vaccination.

Authors:  Melissa B Gilkey; Mo Zhou; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-14       Impact factor: 4.254

6.  Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers' perspectives.

Authors:  Milkie Vu; Adrian R King; Hyun Min Jang; Robert A Bednarczyk
Journal:  Health Educ Res       Date:  2020-12-23

7.  Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina.

Authors:  Nadja A Vielot; Jessica Yasmine Islam; Busola Sanusi; Jenny Myers; Sara Smith; Beth Meadows; Noel T Brewer; Jennifer S Smith
Journal:  Women Health       Date:  2020-08-09

8.  HPV Vaccine Delivery Practices by Primary Care Physicians.

Authors:  Allison Kempe; Sean T O'Leary; Lauri E Markowitz; Lori A Crane; Laura P Hurley; Michaela Brtnikova; Brenda L Beaty; Elissa Meites; Shannon Stokley; Megan C Lindley
Journal:  Pediatrics       Date:  2019-09-16       Impact factor: 7.124

9.  Identifying HPV vaccine narrative communication needs among parents on social media.

Authors:  Philip M Massey; Elikem Togo; Shawn C Chiang; Ann C Klassen; Meredith Rose; Jennifer A Manganello; Amy E Leader
Journal:  Prev Med Rep       Date:  2021-07-07

10.  What Drives Health Professionals to Tweet About #HPVvaccine? Identifying Strategies for Effective Communication.

Authors:  Philip M Massey; Alex Budenz; Amy Leader; Kara Fisher; Ann C Klassen; Elad Yom-Tov
Journal:  Prev Chronic Dis       Date:  2018-02-22       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.